Refrigerated, Ready to Eat Herring in Brine with no brand name as packaged bulk in a plastic bucket labeled in part ***204311**HERRING SU...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0389-2017.
Royal Seafood Baza, Inc. has recalled all pickled products produced on 3/1/2016, 3/2/2016 and also all herring products produced on 2/29/2016 due to possible contamination with Listeria monocytogenes.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0389-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Royal Seafood Baza or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0389-2017.
Royal Seafood Baza
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Royal Seafood Baza Recall FAQ
Royal Seafood Baza is the subject of a food safety report: Refrigerated, Ready to Eat Herring in Brine with no brand name as packaged bulk in a plastic bucket labeled in part ***204311**HERRING SU.... The notice was published on March 18, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 400 units are potentially affected.